UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Index benchmarks provide a transparent yardstick for performance, helping investors gauge risk-adjusted returns and make informed choices.
27,627 articlesAs UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
When a Klaviyo director sold over 9,000 shares, it sparked questions about timing, risk, and company confidence. This...
Investors preparing for the Q4 2025 call on tarsus (tars) 2025 earnings will want a clear, actionable plan. This guid...
A news-driven swing in Ondas stock sparked investor curiosity. This guide breaks down the catalysts, what it means fo...
Investors are weighing a bold claim: prediction: will lose value for XRP. This article breaks down what could drive X...
When a smart-home name rallies, traders pay attention. This piece breaks down why resideo technologies stock popped o...
Snowflake stock soaring has investors buzzing. This guide explains what's driving the rally, how to value the stock, ...
IBM's latest profit warning sheds light on the strength and limits of AI demand, cloud growth, and enterprise spendin...
Hims & Hers Health shares have been hammered, marked by a steep decline over past year. This article breaks down the ...
Today’s stock market today mood shifted as Hewlett Packard Enterprise climbed on the back of Dell’s AI server enthusi...
XRp has logged a year of regulatory and liquidity wins, but the price keeps drifting lower. Analysts say macro headwi...
Netflix’s strategic shift sent a ripple through the market, highlighting how breakup fees and deal terms shape stream...